Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • Resource: Utilizing DATATOP Biospecimens, 2011
    Validation of Alpha-synuclein Oligomers as Biomarker for Parkinson’s Disease

    Objective/Rationale:
    We have reported recently higher levels of α-synuclein oligomers species in cerebral spinal fluid (CSF) from patients clinically diagnosed with Parkinson’s disease (PD) versus...

  • MJFF Research Grant, 2011
    Modulation of Striatal Colinergic Neuronal Activity in LID

    Objective/Rationale:
    The role of striatal cholinergic interneurons (ChIs) in Parkinson’s disease and side effects of treatment like levodopa-induced dyskinesia (LID) have been poorly studied. We have...

  • MJFF Research Grant, 2011
    The Role of Serotonergic and Dopaminergic Mechanisms and their Interaction in L-DOPA Induced Dyskinesias

    Objective/Rationale: 
    Our group has previously shown that brain cells that normally produce serotonin, by taking up L-dopa and then releasing dopamine in an uncontrolled fashion, play a crucial role...

  • Target Validation, 2011
    Tau Oligomers as a Potential Target for Treatment of Parkinson's Disease

    Objective/Rationale:
    Tau pathology is a prominent feature of synucleinopathies, such as Parkinson disease (PD) and dementia with Lewy Bodies (DLB). An emerging view in neurodegeneration is that...

  • Rapid Response Innovation Awards, 2010
    Generation of a Novel Recombinant Protein Activator of GPR88

    Objective/Rationale
    Dopamine replacement therapy activates neurons in a particular region of the brain, the striatum, leading to an improvement in disease symptoms. This action occurs through a...

  • Rapid Response Innovation Awards, 2010
    Circulating microRNAs as Biomarkers for Early Detection of Parkinson's Disease

    Objective/Rationale:
    MicroRNAs (miRNAs) are small, conserved RNAs that interact with target sequences on messenger RNAs. MiRNAs have been proven to regulate the expression of many genes and play...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.